United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The United States specialty generics market size reached US$ 26.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 47.0 Billion by 2028, exhibiting a growth rate (CAGR) of 9.6% during 2023-2028.
Specialty generic drugs are the generic versions of specialty branded drugs once they lose patent protection. These drugs are used to treat life threatening and serious health conditions such as cancer, autoimmune diseases, epilepsy, HIV, hepatitis, multiple sclerosis, rheumatoid arthritis, etc.
Specialty generics are economical compared to specialty drugs as they don’t need to undergo the costly and time-consuming research and development procedures required for their branded versions. Moreover, marketing and promotional expenses for speciality generics are also lower compared to their branded versions. This results in significant savings for patients, government and healthcare providers. Moreover, the market is also being catalysed by a rising ageing population in the United States. This has resulted in an increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, hepatitis, HIV, autoimmune disease, etc. For instance, the American cancer society estimated a total of 1,762,450 new cancer cases and 606,880 deaths from cancer in the United States for 2019. Additionally, the patent expiration of several blockbuster branded specialty drugs is further expected to catalyse the market growth in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the United States specialty generics market report, along with forecasts for the period 2023-2028. Our report has categorized the market based on route of administration, therapeutic application and distribution channel.
Breakup by Route of Administration:
Injectables
Oral
Others
Breakup by Therapeutic Application:
Oncology
Hepatitis
Multiple Sclerosis
HIV
Other Autoimmune Diseases
Others
Breakup by Distribution channel:
Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies
Competitive Landscape:
The leading players in the US specialty generics industry have also been examined in the report.
Key Questions Answered in This Report
1. What was the size of the United States specialty generics market in 2022?
2. What is the expected growth rate of the United States specialty generics market during 2023-2028?
3. What are the key factors driving the United States specialty generics market?
4. What has been the impact of COVID-19 on the United States specialty generics market?
5. What is the breakup of the United States specialty generics market based on the route of administration?
6. What is the breakup of the United States specialty generics market based on the therapeutic application?
7. What is the breakup of the United States specialty generics market based on the distribution channel?
The United States specialty generics market size reached US$ 26.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 47.0 Billion by 2028, exhibiting a growth rate (CAGR) of 9.6% during 2023-2028.
Specialty generic drugs are the generic versions of specialty branded drugs once they lose patent protection. These drugs are used to treat life threatening and serious health conditions such as cancer, autoimmune diseases, epilepsy, HIV, hepatitis, multiple sclerosis, rheumatoid arthritis, etc.
Specialty generics are economical compared to specialty drugs as they don’t need to undergo the costly and time-consuming research and development procedures required for their branded versions. Moreover, marketing and promotional expenses for speciality generics are also lower compared to their branded versions. This results in significant savings for patients, government and healthcare providers. Moreover, the market is also being catalysed by a rising ageing population in the United States. This has resulted in an increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, hepatitis, HIV, autoimmune disease, etc. For instance, the American cancer society estimated a total of 1,762,450 new cancer cases and 606,880 deaths from cancer in the United States for 2019. Additionally, the patent expiration of several blockbuster branded specialty drugs is further expected to catalyse the market growth in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the United States specialty generics market report, along with forecasts for the period 2023-2028. Our report has categorized the market based on route of administration, therapeutic application and distribution channel.
Breakup by Route of Administration:
Injectables
Oral
Others
Breakup by Therapeutic Application:
Oncology
Hepatitis
Multiple Sclerosis
HIV
Other Autoimmune Diseases
Others
Breakup by Distribution channel:
Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies
Competitive Landscape:
The leading players in the US specialty generics industry have also been examined in the report.
Key Questions Answered in This Report
1. What was the size of the United States specialty generics market in 2022?
2. What is the expected growth rate of the United States specialty generics market during 2023-2028?
3. What are the key factors driving the United States specialty generics market?
4. What has been the impact of COVID-19 on the United States specialty generics market?
5. What is the breakup of the United States specialty generics market based on the route of administration?
6. What is the breakup of the United States specialty generics market based on the therapeutic application?
7. What is the breakup of the United States specialty generics market based on the distribution channel?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 GLOBAL SPECIALTY GENERICS MARKET: INTRODUCTION
4.1 What are Specialty Generic Drugs?
4.2 Types of Specialty Generics
5 WHY ARE SPECIALTY GENERICS SO LUCRATIVE?
6 GLOBAL SPECIALTY GENERICS MARKET
6.1 Market Overview
6.2 Market Performance
6.3 Market Breakup by Route of Administration
6.4 Market Breakup by Therapeutic Application
6.5 Market Breakup by Distribution Channel
6.6 Market Breakup by Region
6.7 Market Forecast
7 US SPECIALTY GENERICS MARKET
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Breakup by Route of Administration
7.5 Market Breakup by Therapeutic Application
7.6 Market Breakup by Distribution Channel
7.7 Market Forecast
7.8 SWOT Analysis
7.8.1 Overview
7.8.2 Strengths
7.8.3 Weaknesses
7.8.4 Opportunities
7.8.5 Threats
7.9 Value Chain Analysis
7.10 Porters Five Forces Analysis
7.10.1 Overview
7.10.2 Bargaining Power of Buyers
7.10.3 Bargaining Power of Suppliers
7.10.4 Degree of Competition
7.10.5 Threat of New Entrants
7.10.6 Threat of Substitutes
7.11 Key Market Drivers and Success Factors
8 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
8.1 Injectables
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Oral
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY THERAPEUTIC APPLICATION
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hepatitis
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Multiple Sclerosis
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 HIV
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Other Autoimmune Diseases
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Others
9.6.1 Market Trends
9.6.2 Market Forecast
10 MARKET BREAKUP BY DISTRIBUTION CHANNEL
10.1 Retail Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Specialty Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Hospital Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
11 COMPETITIVE LANDSCAPE
11.1 Market Structure
11.2 Key Players
11.3 Profiles of Key Players
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 GLOBAL SPECIALTY GENERICS MARKET: INTRODUCTION
4.1 What are Specialty Generic Drugs?
4.2 Types of Specialty Generics
5 WHY ARE SPECIALTY GENERICS SO LUCRATIVE?
6 GLOBAL SPECIALTY GENERICS MARKET
6.1 Market Overview
6.2 Market Performance
6.3 Market Breakup by Route of Administration
6.4 Market Breakup by Therapeutic Application
6.5 Market Breakup by Distribution Channel
6.6 Market Breakup by Region
6.7 Market Forecast
7 US SPECIALTY GENERICS MARKET
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Breakup by Route of Administration
7.5 Market Breakup by Therapeutic Application
7.6 Market Breakup by Distribution Channel
7.7 Market Forecast
7.8 SWOT Analysis
7.8.1 Overview
7.8.2 Strengths
7.8.3 Weaknesses
7.8.4 Opportunities
7.8.5 Threats
7.9 Value Chain Analysis
7.10 Porters Five Forces Analysis
7.10.1 Overview
7.10.2 Bargaining Power of Buyers
7.10.3 Bargaining Power of Suppliers
7.10.4 Degree of Competition
7.10.5 Threat of New Entrants
7.10.6 Threat of Substitutes
7.11 Key Market Drivers and Success Factors
8 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
8.1 Injectables
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Oral
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY THERAPEUTIC APPLICATION
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hepatitis
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Multiple Sclerosis
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 HIV
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Other Autoimmune Diseases
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Others
9.6.1 Market Trends
9.6.2 Market Forecast
10 MARKET BREAKUP BY DISTRIBUTION CHANNEL
10.1 Retail Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Specialty Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Hospital Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
11 COMPETITIVE LANDSCAPE
11.1 Market Structure
11.2 Key Players
11.3 Profiles of Key Players
LIST OF TABLES
Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
Table 2: US: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
Table 3: US: Specialty Generics Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 4: US: Specialty Generics Market Forecast: Breakup by Therapeutic Application (in Million US$), 2023-2028
Table 5: US: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: US: Specialty Generics Market: Competitive Structure
Table 7: US: Specialty Generics Market: Key Players`
Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
Table 2: US: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
Table 3: US: Specialty Generics Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 4: US: Specialty Generics Market Forecast: Breakup by Therapeutic Application (in Million US$), 2023-2028
Table 5: US: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: US: Specialty Generics Market: Competitive Structure
Table 7: US: Specialty Generics Market: Key Players`
LIST OF FIGURES
Figure 1: US: Specialty Generics Market: Major Drivers and Challenges
Figure 2: Global: Specialty Generics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2022
Figure 4: Global: Specialty Generics Market: Breakup by Therapeutic Application (in %), 2022
Figure 5: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2022
Figure 6: Global: Specialty Generics Market: Breakup by Region (in %), 2022
Figure 7: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: US: Specialty Generics Market: Sales Value (in Billion US$), 2017-2022
Figure 9: US: Specialty Generics Market: Breakup by Route of Administration (in %), 2022
Figure 10: US: Specialty Generics Market: Breakup by Therapeutic Application (in %), 2022
Figure 11: US: Specialty Generics Market: Breakup by Distribution Channel (in %), 2022
Figure 12: US: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 13: US: Specialty Generics Industry: SWOT Analysis
Figure 14: US: Specialty Generics Industry: Value Chain Analysis
Figure 15: US: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 16: US: Specialty Generics Market (Administration through Injectables): Sales Value (in Million US$), 2017 & 2022
Figure 17: US: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: US: Specialty Generics Market (Oral Administration): Sales Value (in Million US$), 2017 & 2022
Figure 19: US: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: US: Specialty Generics Market (Other Routes of Administration): Sales Value (in Million US$), 2017 & 2022
Figure 21: US: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: US: Specialty Generics Market (Oncology): Sales Value (in Million US$), 2017 & 2022
Figure 23: US: Specialty Generics Market (Oncology) Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: US: Specialty Generics Market (Hepatitis): Sales Value (in Million US$), 2017 & 2022
Figure 25: US: Specialty Generics Market (Hepatitis) Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: US: Specialty Generics Market (Multiple Sclerosis): Sales Value (in Million US$), 2017 & 2022
Figure 27: US: Specialty Generics Market (Multiple Sclerosis) Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: US: Specialty Generics Market (HIV): Sales Value (in Million US$), 2017 & 2022
Figure 29: US: Specialty Generics Market (HIV) Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: US: Specialty Generics Market (Other Autoimmune Diseases): Sales Value (in Million US$), 2017 & 2022
Figure 31: US: Specialty Generics Market (Other Autoimmune Diseases) Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: US: Specialty Generics Market (Other Applications): Sales Value (in Million US$), 2017 & 2022
Figure 33: US: Specialty Generics Market (Other Applications) Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: US: Specialty Generics Market: Sales through Retail Pharmacies (in Million US$), 2017 & 2022
Figure 35: US: Specialty Generics Market Forecast: Sales through Retail Pharmacies (in Million US$), 2023-2028
Figure 36: US: Specialty Generics Market: Sales through Specialty Pharmacies (in Million US$), 2017 & 2022
Figure 37: US: Specialty Generics Market Forecast: Sales through Specialty Pharmacies (in Million US$), 2023-2028
Figure 38: US: Specialty Generics Market: Sales through Hospital Pharmacies (in Million US$), 2017 & 2022
Figure 39: US: Specialty Generics Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2023-2028
Figure 1: US: Specialty Generics Market: Major Drivers and Challenges
Figure 2: Global: Specialty Generics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2022
Figure 4: Global: Specialty Generics Market: Breakup by Therapeutic Application (in %), 2022
Figure 5: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2022
Figure 6: Global: Specialty Generics Market: Breakup by Region (in %), 2022
Figure 7: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: US: Specialty Generics Market: Sales Value (in Billion US$), 2017-2022
Figure 9: US: Specialty Generics Market: Breakup by Route of Administration (in %), 2022
Figure 10: US: Specialty Generics Market: Breakup by Therapeutic Application (in %), 2022
Figure 11: US: Specialty Generics Market: Breakup by Distribution Channel (in %), 2022
Figure 12: US: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 13: US: Specialty Generics Industry: SWOT Analysis
Figure 14: US: Specialty Generics Industry: Value Chain Analysis
Figure 15: US: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 16: US: Specialty Generics Market (Administration through Injectables): Sales Value (in Million US$), 2017 & 2022
Figure 17: US: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: US: Specialty Generics Market (Oral Administration): Sales Value (in Million US$), 2017 & 2022
Figure 19: US: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: US: Specialty Generics Market (Other Routes of Administration): Sales Value (in Million US$), 2017 & 2022
Figure 21: US: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: US: Specialty Generics Market (Oncology): Sales Value (in Million US$), 2017 & 2022
Figure 23: US: Specialty Generics Market (Oncology) Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: US: Specialty Generics Market (Hepatitis): Sales Value (in Million US$), 2017 & 2022
Figure 25: US: Specialty Generics Market (Hepatitis) Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: US: Specialty Generics Market (Multiple Sclerosis): Sales Value (in Million US$), 2017 & 2022
Figure 27: US: Specialty Generics Market (Multiple Sclerosis) Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: US: Specialty Generics Market (HIV): Sales Value (in Million US$), 2017 & 2022
Figure 29: US: Specialty Generics Market (HIV) Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: US: Specialty Generics Market (Other Autoimmune Diseases): Sales Value (in Million US$), 2017 & 2022
Figure 31: US: Specialty Generics Market (Other Autoimmune Diseases) Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: US: Specialty Generics Market (Other Applications): Sales Value (in Million US$), 2017 & 2022
Figure 33: US: Specialty Generics Market (Other Applications) Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: US: Specialty Generics Market: Sales through Retail Pharmacies (in Million US$), 2017 & 2022
Figure 35: US: Specialty Generics Market Forecast: Sales through Retail Pharmacies (in Million US$), 2023-2028
Figure 36: US: Specialty Generics Market: Sales through Specialty Pharmacies (in Million US$), 2017 & 2022
Figure 37: US: Specialty Generics Market Forecast: Sales through Specialty Pharmacies (in Million US$), 2023-2028
Figure 38: US: Specialty Generics Market: Sales through Hospital Pharmacies (in Million US$), 2017 & 2022
Figure 39: US: Specialty Generics Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2023-2028
